Clinical Translation Initiative

About Lunaphore Technologies

Lunaphore Technologies is a pioneering spatial biology company that has developed a unique, chip-based microfluidic platform to automate and accelerate hyperplex tissue analysis. Its flagship COMET™ system utilizes proprietary Fast Fluidic Exchange (FFeX™) and sequential immunofluorescence (seqIF™) technologies to enable rapid, uniform, and reproducible staining of dozens of biomarkers on a single tissue slide. The company targets the rapidly growing research and translational markets, with an open and flexible system designed to democratize spatial biology, and has established key partnerships to expand its technological reach. While currently focused on research, Lunaphore's long-term vision includes developing tools that pave the way to clinical diagnostics.

Therapeutic Areas